Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2

por Shrestha, Prabha, Davis, David A., Jaeger, Hannah K., Stream, Alexandra, Aisabor, Ashley I., Yarchoan, Robert
Publicado 2021

Mechanism and therapeutic implications of pomalidomide-induced immune surface marker upregulation in EBV-positive lymphomas

por Jaeger, Hannah K., Davis, David A., Nair, Ashwin, Shrestha, Prabha, Stream, Alexandra, Yaparla, Amulya, Yarchoan, Robert
Publicado 2023

Pomalidomide increases immune surface marker expression and immune recognition of oncovirus-infected cells

por Davis, David A., Shrestha, Prabha, Aisabor, Ashley I., Stream, Alexandra, Galli, Veronica, Pise-Masison, Cynthia A., Tagawa, Takanobu, Ziegelbauer, Joseph M., Franchini, Genoveffa, Yarchoan, Robert
Publicado 2018

Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide

por Tso, Jonathan L., Yang, Shuai, Menjivar, Jimmy C., Yamada, Kazunari, Zhang, Yibei, Hong, Irene, Bui, Yvonne, Stream, Alexandra, McBride, William H., Liau, Linda M., Nelson, Stanley F., Cloughesy, Timothy F., Yong, William H., Lai, Albert, Tso, Cho-Lea
Publicado 2015